K. Blank

I. Katz, A. Leuchter, G. Cohen, 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Communications Medicine.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

The effect of age and smoking on the hippocampus and memory in late middle age

G. Pearlson, K. Hawkins, S. Khadka, 2018, Hippocampus.

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Public's view of mental health services for the elderly: responses to Dear Abby.

G. Cohen, S. Schultz, K. Sakauye, 2010, Psychiatric services.

Respectful decisions at the end of life.

K. Blank, 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2012, Neurology.

Shifting competency during hospitalization: a model for informed consent decisions.

H. I. Schwartz, K. Blank, 1986, Hospital & community psychiatry.

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

Determinants of Geropsychiatric Inpatient Length of Stay

H. I. Schwartz, K. Blank, J. Robison, 2005, Psychiatric Quarterly.

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Depressive Illness in the Elderly

K. Blank, 1987 .

Screening for depression in middle-aged and older puerto rican primary care patients.

S. Gaztambide, K. Blank, J. Robison, 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients

Anderson M. Winkler, Godfrey D. Pearlson, Karen Blank, 2017, Metabolic Brain Disease.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Norbert Schuff, Adrian Preda, John Kornak, 2012, Proceedings of the National Academy of Sciences.

Geriatric Psychiatry: Ethical and Legal Issues—edited by Barbara Stanley, Ph.D.; American Psychiatric Press, Washington, D.C., 1985, 107 pages, $12, paperbound

K. Blank, 1986 .

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau

Sterling C. Johnson, Nick C Fox, John X. Morris, 2020, Brain communications.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2016, Scientific Reports.

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Keith A. Johnson, Joanne L. Lord, Colleen S. Albers, 2016, Molecular Neurobiology.

Physician-assisted suicide in Connecticut: physicians' attitudes and experiences.

H. I. Schwartz, L. Curry, K. Blank, 2000, Connecticut medicine.

Physician-Assisted Suicide or Voluntary Euthanasia: A Meaningless Distinction for Practicing Physicians?

H. I. Schwartz, L. Curry, K. Blank, 2001, The Journal of Clinical Ethics.

A process for translating evidence-based aphasia treatment into clinical practice

M. Corbetta, F. Tucker, K. Blank, 2005 .

The physician-assisted suicide policy dilemma: a pilot study of the views and experiences of Connecticut physicians.

H. I. Schwartz, L. Curry, K. Blank, 1999, The journal of the American Academy of Psychiatry and the Law.

Instability of attitudes about euthanasia and physician assisted suicide in depressed older hospitalized patients.

H. I. Schwartz, H. Prigerson, K. Blank, 2001, General hospital psychiatry.

COULD ADEQUATE PALLIATIVE CARE OBVIATE ASSISTED SUICIDE?

H. I. Schwartz, L. Curry, K. Blank, 2002, Death studies.

Physicians' Voices on Physician-Assisted Suicide: Looking Beyond the Numbers

H. I. Schwartz, L. Curry, K. Blank, 2000, Ethics & behavior.

Psychiatric Commitment of the Elderly

H. I. Schwartz, K. Blank, W. Vingiano, 1989, Journal of geriatric psychiatry and neurology.

Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.

C. Lyketsos, K. Yaffe, C. Colenda, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE

Keith A. Johnson, Scott Ayton, Joanne L. Lord, 2015, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Sterling C. Johnson, Christine L. Tardif, John X. Morris, 2021, Nature Communications.

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores

Mark T. W. Ebbert, Raymond Scott Turner, Owen Carmichael, 2021, Communications Biology.

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2019, Nature Communications.

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Sterling C. Johnson, John X. Morris, Keith A. Johnson, 2021, Nature Medicine.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Michael W. Weiner, Robert C. Green, Shannon L. Risacher, 2017, Scientific Reports.

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Keith A. Johnson, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Keith A. Johnson, Charles D. Smith, Sherye A. Sirrel, 2020, Nature Communications.

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2021, Translational Psychiatry.

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

Regulation of benzodiazepine prescribing practices: clinical implications.

H. I. Schwartz, K. Blank, 1991, General hospital psychiatry.

Medical students' learning as primary therapists or as participant/observers in a psychiatric clerkship.

J. Oldham, K. Blank, R. D. Kaplan, 1983, The American journal of psychiatry.

The trend of disruption in the functional brain network topology of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Scientific Reports.

Life‐Sustaining Treatment and Assisted Death Choices in Depressed Older Patients

H. I. Schwartz, K. Blank, J. Robison, 2001, Journal of the American Geriatrics Society.

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images

Adrian Preda, Evan Fletcher, Godfrey Pearlson, 2018, Scientific Reports.

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2022, GeroScience.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2018, Molecular Neurobiology.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Case-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settings.

K. Blank, J. Robison, C. Gruman, 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2023, Communications Medicine.

Medicare managed mental health care: a looming crisis.

G. Cohen, S. Schultz, G. Kennedy, 2005, Psychiatric services.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2021, Translational Psychiatry.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Keith A. Johnson, Raymond Scott Turner, Charles D. Smith, 2022, Nature Aging.

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features

Adrian Preda, Evan Fletcher, Charles DeCarli, 2017, Scientific Reports.

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Islem Rekik, Mohamed Ali Mahjoub, Keith A. Johnson, 2018, Scientific Reports.

Prospective study of tardive dyskinesia incidence in the elderly.

J. Lieberman, J. Kane, K. Blank, 1991, JAMA.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019, Nature Communications.

Validation of the Medication Box Task Assessment

K. Blank, A. Chandler, Malcolm Isely, 2017 .

Ataques de Nervios and Psychiatric Disorders in Older Puerto Rican Primary Care Patients

D. Tolin, S. Gaztambide, K. Blank, 2007 .

Anxiety disorders in older Puerto Rican primary care patients.

D. Tolin, S. Gaztambide, K. Blank, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Late-life anxiety disorders among Puerto Rican primary care patients: impact on well-being, functioning, and service utilization.

D. Tolin, G. Diefenbach, K. Blank, 2004, Journal of anxiety disorders.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Keith A. Johnson, Michael W. Paul Ronald Clifford R. Andrew J. William John Weiner Aisen Petersen Jack Saykin Jagust , Sherye A. Sirrel, 2019, Scientific Reports.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

György J. Simon, David T. Jones, Keith A. Johnson, 2020, Scientific Reports.

Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Geriatric anxiety inventory: factor structure and associations with cognitive status.

Laura B. Bragdon, G. Diefenbach, K. Blank, 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Depression in Later-Life Puerto Rican Primary Care Patients: The Role of Illness, Stress, Social Integration, and Religiosity

L. Curry, S. Gaztambide, K. Blank, 2003, International Psychogeriatrics.

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Sherye A. Sirrel, 2020, Scientific Reports.

A cross-national analysis of the psychometric properties of the Geriatric Anxiety Inventory (GAI).

J. Laks, N. Pachana, T. Torsheim, 2019, The journals of gerontology. Series B, Psychological sciences and social sciences.

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images

Sterling C. Johnson, Mirza Faisal Beg, Karteek Popuri, 2017, ArXiv.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2018, Anesthesiology.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

David T. Jones, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2018, Scientific Reports.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Sterling C. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2023, BMC Geriatrics.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Sterling C. Johnson, Sherye A. Sirrel, Alice D. Brown, 2015, Nature Communications.

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

Sterling C. Johnson, Raymond Scott Turner, Alice D. Brown, 2020, Molecular neurodegeneration.

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2024, Alzheimer's research & therapy.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Sterling C. Johnson, David T. Jones, Nick C Fox, 2017, Scientific Reports.